UNICA IRIS Institutional Research Information System

FANTINI, MASSIMO CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 58.991
NA - Nord America 4.310
AS - Asia 499
SA - Sud America 6
AF - Africa 4
OC - Oceania 1
Totale 63.811
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 58.450
US - Stati Uniti d'America 4.298
SE - Svezia 282
CN - Cina 205
SG - Singapore 205
FI - Finlandia 84
GB - Regno Unito 65
DE - Germania 57
VN - Vietnam 32
HK - Hong Kong 27
IN - India 14
CZ - Repubblica Ceca 10
CA - Canada 8
FR - Francia 8
AT - Austria 7
BR - Brasile 6
NL - Olanda 6
GR - Grecia 4
MX - Messico 4
DK - Danimarca 3
JP - Giappone 3
KR - Corea 3
AZ - Azerbaigian 2
EG - Egitto 2
HU - Ungheria 2
IE - Irlanda 2
IS - Islanda 2
LT - Lituania 2
PH - Filippine 2
PK - Pakistan 2
UA - Ucraina 2
AU - Australia 1
BD - Bangladesh 1
BE - Belgio 1
BG - Bulgaria 1
CH - Svizzera 1
IR - Iran 1
LU - Lussemburgo 1
MY - Malesia 1
NG - Nigeria 1
RS - Serbia 1
UG - Uganda 1
YE - Yemen 1
Totale 63.811
Salva come PNG Salva come JPEG
Città #
Cagliari 54.979
Uta 3.321
Fairfield 883
Woodbridge 403
Ashburn 379
Seattle 376
Houston 321
Cambridge 318
Boardman 297
Wilmington 294
Nyköping 253
Ann Arbor 108
Santa Clara 108
Singapore 105
Helsinki 83
Boston 78
Jacksonville 78
Chandler 46
New York 46
Shanghai 44
San Diego 42
Beijing 38
Dearborn 37
Rome 37
Dong Ket 32
Redwood City 31
London 20
Los Angeles 19
Mountain View 17
Milan 15
Nanjing 15
Munich 12
Brno 10
Norwalk 10
Atlanta 9
Kilburn 8
Kunming 8
Redmond 8
Guangzhou 7
Oxford 7
Vienna 6
Chengdu 5
Chiswick 5
Hong Kong 5
Stockholm 5
Toronto 5
Turin 5
Zhengzhou 5
Borås 4
Chicago 4
Florence 4
Jinan 4
Kolkata 4
Mexico City 4
Nanchang 4
Pune 4
Sassari 4
Stockport 4
Wuhan 4
Augusta 3
Collegeville 3
Delhi 3
Fuzhou 3
Hounslow 3
Islington 3
Milazzo 3
Patras 3
Rockville 3
Sadali 3
San Mateo 3
Seoul 3
Amsterdam 2
Angri 2
Anqing 2
Baku 2
Barletta 2
Berlin 2
Cedar Knolls 2
Central 2
Cormano 2
Denver 2
Dublin 2
Fiesole 2
Giza 2
Greensboro 2
Hebei 2
Hefei 2
Isernia 2
Ishøj 2
Jiaxing 2
Krefeld 2
Monte San Giusto 2
Montecassiano 2
Naples 2
New Bedfont 2
Paris 2
Phoenix 2
Piscataway 2
Reading 2
Rende 2
Totale 63.081
Salva come PNG Salva come JPEG
Nome #
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 1.952
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors 1.934
Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history 1.789
Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease 1.526
RORGT-expressing tregs drive the growth of colitis-associated colorectal cancer by controlling IL6 in dendritic cells 1.480
Response Assessed by Ultrasonography as Target of Biological Treatment for Crohn's Disease 1.458
The Resolution of Intestinal Inflammation: The Peace-Keeper's Perspective 1.415
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease 1.244
A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn's disease 1.225
Outcomes of COVID-19 in 79 patients with IBD in Italy: An IG-IBD study 1.179
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study 1.171
Multidimensional Impact of Mediterranean Diet on IBD Patients 1.143
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 1.077
Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis 1.038
Immunological Variables Associated With Clinical and Endoscopic Response to Vedolizumab in Patients With Inflammatory Bowel Diseases 1.007
Reciprocal regulation between Smad7 and Sirt1 in the gut 953
CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide 948
Quercetin and its derivates as antiviral potentials: A comprehensive review 927
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 920
The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation 912
Heligmosomoides polygyrus bakeri infection decreases Smad7 expression in intestinal CD4+ T cells, which allows TGF-b to induce IL-10–producing regulatory T cells that block colitis 903
Update on the Therapeutic Efficacy of Tregs in IBD: Thumbs up or Thumbs down? 893
Tumor infiltrating regulatory t cells in sporadic and colitis-associated colorectal cancer: The red little riding hood and the wolf 871
Are we choosing wisely for inflammatory bowel disease care? The IG-IBD choosing wisely campaign 859
Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death 839
Activation of TGF-β-induced non-Smad signaling pathways during Th17 differentiation 788
A functional role for Smad7 in sustaining colon cancer cell growth and survival 783
GPR120/FFAR4: A Potential New Therapeutic Target for Inflammatory Bowel Disease 782
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth 762
Advanced imaging and Crohn's disease: An overview of clinical application and the added value of artificial intelligence 746
A Pharmacological Batch of Mongersen that Downregulates Smad7 is Effective as Induction Therapy in Active Crohn’s Disease: A Phase II, Open-Label Study 702
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages 664
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 661
Smad7 in intestinal CD4+ T cells determines autoimmunity in a spontaneous model of multiple sclerosis 660
null 617
Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells 610
Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease 609
2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression 597
Smad7 expression in T cells prevents colitis-associated cancer 576
Immune system and gut microbiota senescence in elderly IBD patients 572
Interleukin-21 sustains inflammatory signals that contribute to sporadic colon tumorigenesis 571
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study 561
The impact of translational research on gastroenterology 543
Reprogramming the immune system in IBD 536
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 502
Seroprevalence of SARS-CoV2 in IBD patients treated with biologic therapy 480
Smad7 Controls Resistance of Colitogenic T Cells to Regulatory T Cell-Mediated Suppression 471
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine 460
Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies 453
From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies 451
Intestinal inflammation and colorectal cancer: a double-edged sword? 439
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer 436
The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6 424
Defining Comprehensive Disease Control for use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus Recommendations 422
Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via a p38 Map kinase-dependent induction of SOCS-3 419
Regulation of homeostasis and inflammation in the intestine 411
Interferon-gamma-expressing cells are a major source of interleukin-21 in inflammatory bowel diseases 410
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 405
Mesalazine negatively regulates CDC25A protein expression and promotes accumulation of colon cancer cells in S phase 397
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 394
Drug insight: novel small molecules and drugs for immunosuppression 391
Clinical and epidemiological features of ulcerative colitis patients in Sardinia, Italy: Results from a multicenter study 386
High resolution colonoscopy in live mice 385
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid 383
Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis 380
Lactobacillus paracasei subsp. paracasei B21060 suppresses human T-cell proliferation 377
Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis 376
Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut 373
New players in the cytokine orchestra of inflammatory bowel disease 365
In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy 354
Spatiotemporal patterns of expression of neurotrophins and neurotrophin receptors in mice suggest functional roles in testicular and epididymal morphogenesis 353
A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3alpha, by gut epithelial cells 352
Timing of proper introduction, optimization and maintenance of anti-TNF therapy in IBD: Results from a Delphi consensus 350
Diagnostic delay in adult coeliac disease: An Italian multicentre study 341
Angiogenesis, immune system and growth factors: new targets in colorectal cancer therapy 336
IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1 335
TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling 331
IL10 Secretion Endows Intestinal Human iNKT Cells with Regulatory Functions Towards Pathogenic T Lymphocytes 329
TGF-beta as a T cell regulator in colitis and colon cancer 328
Cytokines: from gut inflammation to colorectal cancer 327
IL-21 comes of age as a regulator of effector T cells in the gut 326
IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa 325
IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes 325
In vitro generation of CD4+ CD25+ regulatory cells from murine naive T cells 323
Selective cyclooxygenase-2 inhibitors and relapse of inflammatory bowel disease 321
Inhibitory Effect of Quercetin on Oxidative Endogen Enzymes: A Focus on Putative Binding Modes 315
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 314
Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 313
Regulation of gut inflammation and th17 cell response by interleukin-21 310
Role of interleukin-21 in inflammation and allergy 306
Telemedicine and remote screening for COVID-19 in inflammatory bowel disease patients: results from the SoCOVID-19 survey 305
EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation 299
Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review 295
IL-6 signaling promotes tumor growth in colorectal cancer 295
Multiple Orocutaneous Extraintestinal Manifestations in Ulcerative Colitis Patient: Complete Response to Ustekinumab 292
Fecal alpha 1-antitrypsin clearance as a marker of clinical relapse in patients with Crohn's disease of the distal ileum 292
Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells 290
A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation 280
Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease 274
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study 260
Totale 62.189
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.425
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.425
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.939 0 0 0 0 0 1.044 824 292 301 197 114 167
2020/202111.977 314 443 429 3.707 2.960 1.125 762 650 179 386 369 653
2021/20225.699 362 462 288 255 479 473 250 494 442 691 871 632
2022/20239.989 797 1.203 1.202 524 662 1.418 640 939 577 649 811 567
2023/202412.823 522 435 373 894 1.421 2.156 2.253 819 617 811 1.347 1.175
2024/202520.267 5.286 6.813 3.029 3.188 1.712 239 0 0 0 0 0 0
Totale 64.159